DK0830143T3 - Anvendelse af leukæmiinhiberende faktor og endothelinantagonister - Google Patents

Anvendelse af leukæmiinhiberende faktor og endothelinantagonister

Info

Publication number
DK0830143T3
DK0830143T3 DK96913814T DK96913814T DK0830143T3 DK 0830143 T3 DK0830143 T3 DK 0830143T3 DK 96913814 T DK96913814 T DK 96913814T DK 96913814 T DK96913814 T DK 96913814T DK 0830143 T3 DK0830143 T3 DK 0830143T3
Authority
DK
Denmark
Prior art keywords
inhibitory factor
leukemia inhibitory
endothelin antagonists
antagonist
endothelin
Prior art date
Application number
DK96913814T
Other languages
English (en)
Inventor
Jennie P Mather
Nicholas F Paoni
Kathleen King
Elizabeth A Luis
Napoleone Ferrara
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0830143T3 publication Critical patent/DK0830143T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK96913814T 1995-04-24 1996-04-17 Anvendelse af leukæmiinhiberende faktor og endothelinantagonister DK0830143T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42738395A 1995-04-24 1995-04-24
PCT/US1996/005498 WO1996033740A1 (en) 1995-04-24 1996-04-17 Use of leukemia inhibitory factor and endothelin antagonists

Publications (1)

Publication Number Publication Date
DK0830143T3 true DK0830143T3 (da) 2003-06-16

Family

ID=23694642

Family Applications (2)

Application Number Title Priority Date Filing Date
DK02016730T DK1287832T3 (da) 1995-04-24 1996-04-17 Anvendelse af antagonist af leukæmiinhiberende faktor
DK96913814T DK0830143T3 (da) 1995-04-24 1996-04-17 Anvendelse af leukæmiinhiberende faktor og endothelinantagonister

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK02016730T DK1287832T3 (da) 1995-04-24 1996-04-17 Anvendelse af antagonist af leukæmiinhiberende faktor

Country Status (12)

Country Link
EP (2) EP0830143B1 (da)
JP (1) JPH11504332A (da)
AT (2) ATE313333T1 (da)
AU (1) AU702375B2 (da)
CA (1) CA2214636C (da)
DE (2) DE69626510T2 (da)
DK (2) DK1287832T3 (da)
ES (1) ES2254564T3 (da)
IL (1) IL117998A (da)
MX (1) MX9707939A (da)
WO (1) WO1996033740A1 (da)
ZA (1) ZA963274B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU753197B2 (en) 1998-07-06 2002-10-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Compositions and methods for in vitro fertilization
WO2004030519A2 (en) * 2002-09-30 2004-04-15 Duke University Thymic atrophy
JP2011231014A (ja) * 2008-08-27 2011-11-17 Keiichi Fukuda 心不全の治療剤
EP2371860A1 (en) * 2010-04-05 2011-10-05 Fundació Privada Institut d'Investigació Oncològica de Vall d'Hebron Antibody recognising human leukemia inhibitory factor (LIF) and use of anti-LIF antibodies in the treatment of diseases associated with unwanted cell proliferation
WO2018115960A1 (en) 2016-12-19 2018-06-28 Mosaic Biomedicals, S.L. Antibodies against lif and uses thereof
EP4321219A3 (en) 2016-12-19 2024-05-15 Medimmune Limited Antibodies against lif and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4231393A (en) * 1992-05-08 1993-12-13 Genentech Inc. Antibodies to leukemia inhibitory factor
WO1995008550A1 (en) * 1993-09-24 1995-03-30 Abbott Laboratories Endothelin antagonists

Also Published As

Publication number Publication date
DE69635630T2 (de) 2006-08-10
DK1287832T3 (da) 2006-05-01
ATE233570T1 (de) 2003-03-15
WO1996033740A1 (en) 1996-10-31
ATE313333T1 (de) 2006-01-15
EP1287832A2 (en) 2003-03-05
CA2214636A1 (en) 1996-10-31
DE69626510D1 (de) 2003-04-10
IL117998A (en) 2001-04-30
EP0830143B1 (en) 2003-03-05
ES2254564T3 (es) 2006-06-16
DE69626510T2 (de) 2003-12-11
EP0830143A1 (en) 1998-03-25
EP1287832A3 (en) 2003-04-16
ZA963274B (en) 1997-10-24
JPH11504332A (ja) 1999-04-20
EP1287832B1 (en) 2005-12-21
MX9707939A (es) 1997-12-31
DE69635630D1 (de) 2006-01-26
CA2214636C (en) 2009-12-22
AU702375B2 (en) 1999-02-18
IL117998A0 (en) 1996-08-04
AU5665896A (en) 1996-11-18

Similar Documents

Publication Publication Date Title
DK0445255T4 (da) Anvendelse af hyaluronsyre i kombination med ascorbinsyre, antitumormidler og/eller NSAID's til behandling af cancer
DE69230140D1 (de) Antivirale nucleosidkombination
DK1294757T3 (da) Glucagonlignende peptid 1-analoger
FI894095A0 (fi) Vaermare foer anvaendning i mikrovaogsugnar.
NO960173L (no) Tri-substituerte imidazoler med multipel-terapeutiske egenskaper
FI923158A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoidossa
AU9064991A (en) Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy
DK0830143T3 (da) Anvendelse af leukæmiinhiberende faktor og endothelinantagonister
ITMI912509A1 (it) Uso della nimesulide nel trattamento della cataratta
DE59004277D1 (de) Copolymerisat sowie dessen Verwendung.
TR199801988T2 (xx) Kalp yetmezli�inin endotelin antagonistleri ile tedavisi i�in y�ntem.
ATE154507T1 (de) Dentalwerkstoffe auf basis von (meth)-acrylaten
NO894008L (no) Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme.
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
NO893761D0 (no) Skap med utleveringsanordning.
IT8519042A0 (it) Impiego di chinoloni nel trattamento di malattie cardiache.!
DE68906245D1 (de) Therapeutisches mittel gegen aids.
NO875189L (no) Knapporgan med festeanordning.
FI952018L (fi) BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskriptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon
DK0661058T3 (da) Anvendelse af bradykininantagonister til behandling af virussygdomme
RU96120518A (ru) Средство для лечения больных хроническим простатитом
BR0009642A (pt) Terapia de leucemia mielocìtica crÈnica
DE3586781D1 (de) Behandlungsverfahren gegen hohen blutdruck bei wirbeltieren.
AU4449896A (en) Use of beta-cell-tropin (ACTH 22-39) antagonists in the treatment of type II diabetes and associated diseases
FI914878A0 (fi) Hydroxylerade inhibitorer foer hiv:s reverserade transkriptas.